HC9 Ventures, an early-stage venture firm, announced the close of an $83 million vehicle that will invest in Seed and Series A healthcare software and services companies. The fund’s founders previously worked at Leverage Health and founded the venture arm at New York-Presbyterian. To date, the firm has invested in three companies.
PayZen announces $200M credit line
Care.ai, a platform optimizing clinical and operational workflows, closed a $27 million funding round. The round was led by Crescent Cove Advisors, a multi-asset investment firm focused on technology investments, to accelerate growth and scale deployments of Care.ai’s smart care facility platform throughout the U.S. Care.ai has deployed it in 1,500 facilities across the U.S., including hospitals as well as skilled nursing and assisted living centers.
Can pharma prop up the digital health recession?
Temedica, a Munich-based company that develops digital companion products for pharma companies, extended its Series B funding to raise another €25 million ($25.9 U.S.). The expansion of the financing round was led by existing investors MIG Capital as well as a Munich-based family office. Temedica announced a partnership in March with Bristol Myers Squibb to develop an app for psoriasis patients.
Pharma dives feet first into the digital health world
More deals and funding rounds:
SonderMind, a digital behavioral health platform, acquired Total Brain, a neuroscience-based mental health and brain performance app.
CardieX, a cardiovascular health technology company, acquired Blumio, a cardiovascular device company.
RedBrick AI, a medical imaging platform raised $4.6 million in seed funding.
Capitol, an AI-powered analytics and decision support platform, closed a $10 million seed round.
If there is a digital health funding or M&A deal that we missed from this past week here, please email us.
Digital Health Business & Technology’s data team contributed to this roundup.
